The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Bacterial membrane lipids in the action of antimicrobial agents
Abstract
Many antimicrobial agents that target bacteria are cationic and can interact with the anionic lipid components that are exposed on the bacterial membrane. Bacteria vary widely in the nature of the major lipid components that are in the cell membrane. Those bacteria with both anionic as well as zwitterionic or neutral lipids can be induced to form domains in the presence of antimicrobial peptides possessing several cationic charges. This segregation of anionic and zwitterionic lipids into domains can result in the arrest of cell growth or in cell death. Such agents are generally more toxic to Gram‐negative bacteria, than to Gram‐positive ones. These findings emphasize the importance of the lipid composition of bacterial membranes in determining the susceptibility of the organism to the action of certain antimicrobial agents. Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Lipid domains in bacterial membranes and the action of antimicrobial agents
Epand, R. M., & Epand, R. F. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.023 · Cited by 624
Self-citationMagainins as paradigm for the mode of action of pore forming polypeptides
Matsuzaki, K. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00014-8 · Cited by 589
Ernst, C. M., Staubitz, P., Mishra, N. N., Yang, S.-J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 368
Hornung, V., & Latz, E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2690 · Cited by 364
Lipid domains in bacterial membranes
Matsumoto, K., Kusaka, J., Nishibori, A., & Hara, H. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05317.x · Cited by 289
Li, X., Li, Y., Han, H., Miller, D. W., & Wang, G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0584875 · Cited by 284
Almeida, P. F., & Pokorny, A. (2009) · Biochemistry · doi:10.1021/bi900914g · Cited by 265
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Smoothed orientational order profile of lipid bilayers by 2H-nuclear magnetic resonance
Lafleur, M., Fine, B., Sternin, E., Cullis, P. R., & Bloom, M. (1989) · Biophysical Journal · doi:10.1016/s0006-3495(89)82749-3 · Cited by 233
Mishra, N. N., Yang, S.-J., Sawa, A., Rubio, A., Nast, C. C., Yeaman, M. R., & Bayer, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-08 · Cited by 216
Lehrer, R. I., Barton, A., & Ganz, T. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90414-0 · Cited by 211
Antimicrobial peptides: discovery, design and novel therapeutic strategies
(2010) · CABI eBooks · doi:10.1079/9781845936570.0000 · Cited by 176
Domains in bacterial membranes and the action of antimicrobial agents
Epand, R. M., & Epand, R. F. (2009) · Molecular BioSystems · doi:10.1039/b900278m · Cited by 174
Self-citationBacterial Membranes as Predictors of Antimicrobial Potency
Epand, R. M., Rotem, S., Mor, A., Berno, B., & Epand, R. F. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8062327 · Cited by 172
Self-citationCovalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites
Marchand, C., Krajewski, K., Lee, H.-F., Antony, S., Johnson, A. A., Amin, R., Roller, P., Kvaratskhelia, M., & Pommier, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl667 · Cited by 171
Arouri, A., Dathe, M., & Blume, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.022 · Cited by 160
Sigmoidal Concentration Dependence of Antimicrobial Peptide Activities: A Case Study on Alamethicin
Chen, F.-Y., Lee, M.-T., & Huang, H. W. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75452-0 · Cited by 159
pH‐dissociation characteristics of cardiolipin and its 2′‐deoxy analogue
Kates, M., Syz, J., Gosser, D. K., & Haines, T. H. (1993) · Lipids · doi:10.1007/bf02537494 · Cited by 152
Synthetic Antimicrobial Oligomers Induce a Composition-Dependent Topological Transition in Membranes
Yang, L., Gordon, V. D., Mishra, A., Som, A., Purdy, K. R., Davis, M. A., Tew, G. N., & Wong, G. C. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072310o · Cited by 134
Jean-Francois, F. L., Castano, S., Desbat, B., Odaert, B., Roux, M., Metz‐Boutigue, M., & Dufourc, É. J. (2008) · Biochemistry · doi:10.1021/bi800448h · Cited by 122
Camargo, I. L. B. D. C., Neoh, H., Cui, L., & Hiramatsu, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00417-08 · Cited by 113
Epand, R. F., Wang, G., Berno, B., & Epand, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00321-09 · Cited by 94
Self-citationJoshi, S., Bisht, G. S., Rawat, D. S., Kumar, A., Kumar, R., Maiti, S., & Pasha, S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.06.016 · Cited by 88
Lewis, R. N. A. H., Zweytick, D., Pabst, G., Lohner, K., & McElhaney, R. N. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.094003 · Cited by 80
van der Kraan, M. I. A., van Marle, J., Nazmi, K., Groenink, J., Hof, W. V. ‘., Veerman, E. C. I., Bolscher, J. G. M., & Amerongen, A. V. N. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.011 · Cited by 76
Epand, R. M., Epand, R. F., Arnusch, C. J., Papahadjopoulos‐Sternberg, B., Wang, G., & Shai, Y. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.03.012 · Cited by 69
Self-citationOreopoulos, J., Epand, R. F., Epand, R. M., Epand, R. M., Epand, R. M., & Yip, C. M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4327 · Cited by 66
Self-citationAnalogous oligo‐acyl‐lysines with distinct antibacterial mechanisms
Rotem, S., Radzishevsky, I. S., Bourdetsky, D., Navon‐Venezia, S., Carmeli, Y., & Mor, A. (2008) · The FASEB Journal · doi:10.1096/fj.07-105015 · Cited by 65
Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit
Maragakis, L. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e6cbc5 · Cited by 64
Shin, S., Kim, J., Lee, J., Jung, K., Hwang, J., Lee, J., Lee, D. G., Kim, I., Shin, S. Y., & Kim, Y. (2009) · Journal of Peptide Science · doi:10.1002/psc.1156 · Cited by 20
Cited by
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
The expanding scope of antimicrobial peptide structures and their modes of action
Nguyen, L. T., Haney, E. F., & Vogel, H. J. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.05.001 · Cited by 1,604
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
Self-citationPeptide Design Principles for Antimicrobial Applications
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.12.015 · Cited by 438
Antimicrobial Peptides Targeting Gram-Positive Bacteria
Malanovic, N., & Lohner, K. (2016) · Pharmaceuticals · doi:10.3390/ph9030059 · Cited by 420
Metadata
- Authors
- Epand, R. M., & Epand, R. F.
- Venue
- Journal of Peptide Science
- Publisher
- Wiley
- Published
- 2010-11-30
- Volume
- 17
- Issue
- 5
- Pages
- 298-305
- ISSN
- 1075-2617 (ISSN-L)
- 1099-1387
- OpenAlex
- W2141682747
- Cited by
- 332
- References
- 33
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.